British journal of clinical pharmacology
Can we identify a post-Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repens.
Filippo Firenzuoli, Bernardo Firenzuoli, Vittorio Mascherini, Niccolò Firenzuoli, Francesca Menniti-Ippolito, Ilaria Ippoliti, Valentina Maggini, Eugenia Gallo, Alessandro Cuomo, Andrea Fagiolini, Gian Franco Gensini, Fabio Firenzuoli
Published: 202610.1002/bcp.70442
Abstract
Serenoa repens is widely used for benign prostatic hyperplasia and androgenetic alopecia due to its 5alpha-reductase inhibitory activity. However, emerging reports describe sexual, psychiatric and somatic adverse effects resembling a post-finasteride…
Preview only. Read the full abstract at the source